ATAI Life Sciences NV (ATAI)
2.11
+0.06
(+2.93%)
USD |
NASDAQ |
May 06, 16:00
2.115
0.00 (0.00%)
After-Hours: 20:00
ATAI Life Sciences Profit Margin (Quarterly): -101.6K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -101.6K% |
| September 30, 2023 | |
| June 30, 2023 | -19.21K% |
| March 31, 2023 | -89.55K% |
| December 31, 2022 | -118.4K% |
| September 30, 2022 | -141.2K% |
| Date | Value |
|---|---|
| June 30, 2022 | -21.54K% |
| March 31, 2022 | |
| December 31, 2021 | -38.64K% |
| September 30, 2021 | -11.71K% |
| June 30, 2021 | |
| March 31, 2021 | 3.46% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-141.2K%
Minimum
Sep 2022
3.46%
Maximum
Mar 2021
-60.21K%
Average
-38.64K%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| Affimed NV | -4.89K% |
| InflaRx NV | -696.8K% |
| MorphoSys AG | 81.70% |
| BioNTech SE | 30.96% |
| Immatics NV | -164.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.29% |
| Return on Assets | -13.95% |
| Return on Invested Capital | -15.31% |
| Operating Margin (Quarterly) | -172.9K% |
| Return on Net Operating Assets | -311.8% |